Tuesday, August 16, 2016

BRIEF-Indivior Plc announces positive top-line phase 3 study results for RBP-6000

* Announces positive top-line phase 3 pivotal study results

for rbp-6000 buprenorphine monthly depot for treatment of opioid

use disorder

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)